BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17410941)

  • 1. [Epigenetics and cancer].
    Kern I; Rossier MF; Chappuis PO
    Rev Med Suisse; 2007 Feb; 3(100):540-2, 544-5. PubMed ID: 17410941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of epigenetics in urological cancers.
    Ramachandran K; Soloway MS; Singal R; Manoharan M
    Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of epigenetic alterations in pancreatic cancer.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epigenetics-related diseases and analytic methods].
    Soejima H
    Rinsho Byori; 2009 Aug; 57(8):769-78. PubMed ID: 19764412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
    Clark SJ
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the epigenetic code of cancer for therapy.
    Smith LT; Otterson GA; Plass C
    Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms involved in epigenetic alterations in cancer].
    Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic targets in cancer epidemiology.
    Dumitrescu RG
    Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new frontier in cancer research: deciphering cancer epigenetics.
    Lohrum M; Stunnenberg HG; Logie C
    Int J Biochem Cell Biol; 2007; 39(7-8):1450-61. PubMed ID: 17442611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer epigenetics.
    Taby R; Issa JP
    CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer susceptibility: epigenetic manifestation of environmental exposures.
    Weidman JR; Dolinoy DC; Murphy SK; Jirtle RL
    Cancer J; 2007; 13(1):9-16. PubMed ID: 17464241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
    Reamon-Buettner SM; Borlak J
    Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations and cancer: new targets for therapy.
    Allen A
    IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on the relationship between nutrition and cancer epigenetics---histone modification mechanisms].
    Teng LJ; Li K
    Ai Zheng; 2007 Sep; 26(9):1034-8. PubMed ID: 17927868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective.
    Roberti A; La Sala D; Cinti C
    J Cell Physiol; 2006 Jun; 207(3):571-81. PubMed ID: 16250021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.